Bronchial Hyperreactivity
14
2
2
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
7.1%
1 terminated out of 14 trials
88.9%
+2.4% vs benchmark
7%
1 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (14)
Reversibility of Bronchial Obstruction in Children Born Preterm
Safe, Effective and Cost-Effective Oxygen Saturation Targets for Children and Adolescents With Respiratory Distress: a Randomized Controlled Trial
Contrasting Dosivent With Plus Flow Vu Spacer in Bronchial Hyperreactivity Participants
Methacholine Challenge Testing: Comparison of FEV1 and IOS Parameters in Adult Asthma Patients
Towards Life-Long Healthy Lungs: A Multidisciplinary Follow-up Framework for Preterm Infants
Telemedicine in the Generals Practitioners Office
Diagnostic Utility of Different Airway Resistance Assessment Techniques in the Methacholine Challenge Test
Prospective Evaluation of the Efficacy of Palivizumab Administration in Children Born at 29-32 Weeks of Gestation
Different End Points for Bronchial Hyperactivity (BHR) Tests.
The Effect of Montelukast in Patients With Chronic Cough and Bronchial Hyperreactivity
Comparison of Two Methods of Bronchial Methacholine Provocation
Early Antiinflammatory Treatment of Asthma
Measurement of Exhaled Nitric Oxide (NO) and Bronchial Provocation Test With Mannitol as a Predictor of Response to Inhaled Corticosteroids in Chronic Cough
Influence of Nutrition on Nasal and Bronchial Affliction in Patients With Allergy on Grass-Pollen